ES2111068T3 - Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma. - Google Patents

Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma.

Info

Publication number
ES2111068T3
ES2111068T3 ES92911883T ES92911883T ES2111068T3 ES 2111068 T3 ES2111068 T3 ES 2111068T3 ES 92911883 T ES92911883 T ES 92911883T ES 92911883 T ES92911883 T ES 92911883T ES 2111068 T3 ES2111068 T3 ES 2111068T3
Authority
ES
Spain
Prior art keywords
protein
tap
trichosanthes
same
therapeutic uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911883T
Other languages
English (en)
Inventor
Sylvia Lee-Huang
Philip L Huang
Hao-Chia Chen
Hsiang-Fu Kung
Peter Huang
Henry I Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
New York University NYU
Abraxis Bioscience LLC
Original Assignee
US Department of Health and Human Services
American Bioscience Inc
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, American Bioscience Inc, New York University NYU filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2111068T3 publication Critical patent/ES2111068T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UNA NUEVA PROTEINA, DENOMINADA TAP 29, OBTENIBLE A PARTIR DE LA PLANTA TRICHOSANTHES KIRILOWII O PRODUCIDA POR MEDIOS DE RECOMBINACION SE USA PARA TRATAR INFECCIONES DE VIH O TUMORES. EN TRATAMIENTO DE INFECCIONES DE VIH, LA PROTEINA SE ADMINISTRA SOLA O EN CONJUNCION CON TERAPIAS CONVENCIONALES PARA SIDA. TAMBIEN SE PROVEEN PROCESOS PARA PURIFICAR LA PROTEINA, SECUENCIAS DE DNA CODIFICANDO LA PROTEINA, ANFITRIONES QUE EXPRESAN LA PROTEINA, METODOS DE RECOMBINACION DE DNA PARA EXPRESAR LA PROTEINA, Y ANTICUERPOS ESPECIFICOS PARA LA PROTEINA.
ES92911883T 1991-04-15 1992-04-15 Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma. Expired - Lifetime ES2111068T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68512691A 1991-04-15 1991-04-15

Publications (1)

Publication Number Publication Date
ES2111068T3 true ES2111068T3 (es) 1998-03-01

Family

ID=24750879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911883T Expired - Lifetime ES2111068T3 (es) 1991-04-15 1992-04-15 Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma.

Country Status (11)

Country Link
US (1) US5532214A (es)
EP (1) EP0580782B1 (es)
JP (1) JPH06506949A (es)
AT (1) ATE159032T1 (es)
AU (1) AU672749B2 (es)
CA (1) CA2108467A1 (es)
DE (1) DE69222636T2 (es)
DK (1) DK0580782T3 (es)
ES (1) ES2111068T3 (es)
GR (1) GR3025841T3 (es)
WO (1) WO1992018148A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635384A (en) * 1990-06-11 1997-06-03 Dowelanco Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
US5681815A (en) * 1993-06-28 1997-10-28 Sophie Chen Antiviral and antitumor agents
WO1999003492A1 (en) * 1997-07-16 1999-01-28 Sophie Chen Antiviral and antitumor agents
CN1152051C (zh) * 2000-08-02 2004-06-02 北京翔天牧生物科技有限公司 一种天花粉蛋白突变体及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601680B1 (fr) * 1986-07-15 1990-06-29 Sanofi Sa Inhibiteur de la synthese proteique, procede d'isolement, utilisation et compositions pharmaceutiques en contenant
US4985541A (en) * 1987-04-10 1991-01-15 Zymogenetics, Inc. Novel cytotoxic protein
US5149528A (en) * 1987-04-10 1992-09-22 Zymogenetics, Inc. Cytotoxic protein from Trichosanthes kirilowii
US4795739A (en) * 1987-05-29 1989-01-03 Gene Labs, Inc. Method of inhibiting HIV
US4869903A (en) * 1987-05-29 1989-09-26 Genelabs Incorporated Method of selectively inhibiting HIV
US5077390A (en) * 1989-04-04 1991-12-31 Genelabs, Incorporated Purified trichosanthin and method of preparation
EP0466817A1 (en) * 1989-04-04 1992-01-22 Genelabs Technologies, Inc. Recombinant trichosanthin and coding sequence
US5166056A (en) * 1989-04-04 1992-11-24 Genelabs Incorporated Recombinant trichosanthin and coding sequence

Also Published As

Publication number Publication date
EP0580782A4 (en) 1995-04-26
CA2108467A1 (en) 1992-10-16
DE69222636D1 (de) 1997-11-13
WO1992018148A1 (en) 1992-10-29
AU1973792A (en) 1992-11-17
DK0580782T3 (da) 1998-05-04
ATE159032T1 (de) 1997-10-15
DE69222636T2 (de) 1998-02-05
GR3025841T3 (en) 1998-04-30
JPH06506949A (ja) 1994-08-04
EP0580782A1 (en) 1994-02-02
EP0580782B1 (en) 1997-10-08
US5532214A (en) 1996-07-02
AU672749B2 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
DE69233143D1 (de) Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung
EP0552257A4 (en) A plant protein useful for treating tumors and hiv infection
ES2111068T3 (es) Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma.
DE69332583D1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
EP0321094A3 (en) Treatment of factor viii inhibitors
WO2001075041A3 (fr) Nouveau polypeptide, proteine humaine associee a l'epilepsie 11, et polynucleotide codant pour ce polypeptide
WO2001075008A3 (fr) Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075020A3 (fr) Nouveau polypeptide, neuroproteine humaine y 11, et polynucleotide codant pour ce polypeptide
Karachentsev et al. Cryogenic methods in different chronic autoimmune thyroidite forms treatment; Kryiovpliv v lyikuvannyi ryiznikh form khronyichnogo autoyimunnogo tiroyiditu
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075001A3 (fr) Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001078755A3 (fr) Nouveau polypeptide, proteine humaine de mutation 9 de l'ataxie-telangiectasie, et polynucleotide codant pour ce polypeptide
WO2001075059A3 (fr) Nouveau polypeptide, proteine humaine 11 de regulation de gtp, et polynucleotide codant pour ce polypeptide
WO2002000821A3 (fr) Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
JPS52148487A (en) Filter membrane of hollow fiber
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide
WO2001075026A3 (fr) Nouveau polypeptide, eucaryote acetyl transferase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075050A3 (fr) Nouveau polypeptide, proteine humaine associee au transport vesiculaire 9, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580782

Country of ref document: ES